Spotlight: Chinese biotech chooses NY CRO for cancer trial

Beverly Hills, CA, cancer biopharma company Rich Pharmaceuticals has extended its agreement with Princeton, NJ-based CRO Theradex Systems to manage its clinical sites in the U.S. Through this continued deal, Theradex will lead Rich Pharma's new Phase I/II clinical for the treatment of acute myelocytic leukemia and myelodysplastic syndrome patients in the region. Release

> China-based biotech Henlius has chosen NY cloud software CRO Medidata to help it bring "operational efficiencies" to its ongoing Phase III cancer drug trial in its native country. Release

> HealthCarePoint, a Texas-based healthcare and clinical research networking-tech company, has completed global testing of its next-gen BlueCloud business model to help healthcare groups and CROs better manage clinical trials. Release


Overcoming Risk in Oncology Drug Development

Oncology drug development is full of potential obstacles and risks, and you must carefully plan each step. Download this whitepaper for tips on finding the fast track. Premier Research. Built for Biotech.

Suggested Articles

Data firm Syapse has begun working with the FDA to help bring real-world evidence to bear on the agency’s decisions to approve cancer drugs.

The People-Centered Research Foundation tapped Datavant to de-identify real-world data across its national clinical research network.

Boehringer Ingelheim and MD Anderson Cancer Center have joined forces to create a “virtual” R&D hub so the pair can work on cancer drugs.